Global Sleep Apnea Market 2018-2023 - North America Dominates Due to High Incidence of SDB in the US - ResearchAndMarkets.com

DUBLIN--()--The "Global Sleep Apnea Market - Segmented by Diagnostic Devices, by Therapeutic Devices, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.

The sleep apnea market is expected to witness a CAGR of 7.5% during the forecast period.

It has been observed that one in every five adults have mild obstructive sleep apnea (OSA) and one in fifteen adults have moderate to severe obstructive sleep apnea (OSA). It has also been detected that 9% of middle-aged women and 25% of middle-aged men suffer from OSA, while 75% of severe sleep-disordered breathing (SDB) cases remain undiagnosed.

The number of OSA patients is increasing with the aging population and growing levels of obesity. The prevalence of OSA is approximately 3% to 7% in adult men and 2% to 5% in adult women, in the general population. Additionally, up to 50% of the adult population are snorers, which is an indicator of the presence of OSA and a significant social problem. Thus, increasing incidence of the sleep apnea is fuelling the growth of the sleep apnea devices market.

Additionally, increasing awareness among the patient population in developing countries, favorable government initiatives, and upcoming technological advancements, are also driving the sleep apnea devices market.

North America dominates the global market due to the high incidence of sleep-disordered breathing (SDB) in the United States. The European region is projected to register the highest CAGR during the forecast period, due to the use of noninvasive and painless cardiorespiratory monitors that are used to assess the oxygen saturation level of arterial blood.

Key Developments in the Market

  • January 2018: ResMed joined MedTech Europe, to make innovative medical technology and health solutions that are available to people
  • November 2017: SleepScore Labs launched advanced sleep improvement system

Key Topics Covered

1. Introduction

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

7. Market Segmentation

8. Competitive Landscape

9. Key Players

  • Cadwell Laboratories Inc.
  • Carefusion Corporation
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Invacare Corporation
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Resmed
  • Teleflex Incorporated

10. Future of the Market

For more information about this report visit https://www.researchandmarkets.com/research/sz84r7/global_sleep?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Respiratory Drugs, Respiratory Devices

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Diagnostics, Respiratory Drugs, Respiratory Devices